FORM 10-QSB

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549

                   QUARTERLY REPORT UNDER SECTION 13 OR 15 (D)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

For Quarter Ended March 31, 2000


Commission File Number 1-8635

                          AMERICAN MEDICAL ALERT CORP.
             (Exact Name of Registrant as Specified in its Charter)

         New York                                               11-2571221
(State or other jurisdiction of                              (I.R.S. Employer
incorporation or organization)                            Identification Number)

                3265 Lawson Boulevard, Oceanside, New York 11572
                    (Address of principal executive offices)
                                   (Zip Code)

                                 (516) 536-5850

              (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. Yes X No __

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest  practicable  date:  6,414,111 shares of $.01 par
value common stock as of May 8, 2000.


<PAGE>



                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY


<TABLE>
<CAPTION>

                                            INDEX                                               PAGE

Part  I  Financial Information
<S>                                                                                              <C>
                  Report of Independent Accountants...............................................1

                  Condensed Consolidated Balance Sheets for March 31, 2000
                  and December 31, 1999...........................................................2

                  Condensed Consolidated Statements of Income for the
                  Three Months Ended March 31, 2000 and 1999......................................3

                  Condensed Consolidated Statements of Cash Flows for
                  the Three Months Ended March 31, 2000 and 1999................................4-5

                  Notes to Condensed Consolidated Financial Statements............................6

                  Management's Discussion and Analysis of
                  Financial Condition and Results of Operations...................................8

Part II  Other Information.......................................................................11

</TABLE>


<PAGE>


REPORT OF INDEPENDENT ACCOUNTANTS

Board of Directors and Shareholders
American Medical Alert Corp. and Subsidiary
Oceanside, New York

We have reviewed the condensed  consolidated  balance sheet of American  Medical
Alert  Corp.  and  Subsidiary  as of March 31,  2000 and the  related  condensed
consolidated statements of income and cash flows for the three-month period then
ended.  These  financial  statements  are the  responsibility  of the  company's
management.

We conducted our review in accordance with standards established by the American
Institute  of  Certified  Public  Accountants.  A review  of  interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with  generally  accepted  auditing  standards,  the  objective  of which is the
expression of an opinion  regarding the financial  statements  taken as a whole.
Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the condensed consolidated financial statements referred to above for
them to be in conformity with generally accepted accounting principles.

We have  previously  audited,  in accordance  with generally  accepted  auditing
standards,  the  consolidated  balance  sheet as of December 31,  1999,  and the
related consolidated  statements of income,  shareholders' equity and cash flows
for the year then ended (not presented herein); and in our report dated February
17, 2000 we expressed an  unqualified  opinion on those  consolidated  financial
statements.  In our  opinion,  the  information  set  forth in the  accompanying
condensed  consolidated balance sheet as of December 31, 1999, is fairly stated,
in all material  respects,  in relation to the  consolidated  balance sheet from
which it has been derived.

The accompanying condensed  consolidated  statements of income and cash flows of
American  Medical Alert Corp. and Subsidiary  for the  three-month  period ended
March 31, 1999 were not audited (or reviewed) by us and, accordingly,  we do not
express an opinion (or any other form of assurance) on them.



May 10, 2000                                 /s/ Margolin, Winer & Evans LLP


                                      -1-
<PAGE>


ITEM 1. FINANCIAL STATEMENTS.
        ---------------------

                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY
                      CONDENSED CONSOLIDATED BALANCE SHEETS

                                     ASSETS
<TABLE>
<CAPTION>

                                                                                       March 31, 2000          Dec. 31, 1999*
                                                                                        (Unaudited)
                                                                                    ---------------------    --------------------
CURRENT ASSETS
<S>                                                                                 <C>                      <C>
     Cash                                                                           $           230,782       $         953,734
     Accounts and notes receivable
     (net of allowance for doubtful accounts of $75,000)                                      2,673,223               2,255,640
     Inventory                                                                                  865,201                 791,572
     Prepaid expenses and other current assets                                                  362,983                 342,548
     Deferred income tax benefit                                                                156,000                 156,000
                                                                                    ---------------------    --------------------

     Total Current Assets                                                                     4,288,189               4,499,494

INVENTORY OF MEDICAL DEVICES HELD FOR LEASE - AT COST                                         1,075,000                 988,000
FIXED ASSETS
     (Net of accumulated depreciation and amortization)                                       6,137,371               5,503,347

OTHER ASSETS                                                                                  1,085,436                 393,680
                                                                                    ---------------------    --------------------

TOTAL ASSETS                                                                        $       12,585,996       $      11,384,521
                                                                                    =====================    ====================

                                              LIABILITIES AND SHAREHOLDERS' EQUITY

CURRENT LIABILITIES:
     Accounts payable                                                               $           661,383       $         305,320
     Accrued expenses                                                                           202,492                 242,373
     Current portion of long term debt                                                          183,109                  98,801
                                                                                    ---------------------    --------------------
     Total Current Liabilities                                                                1,046,984                 646,494
                                                                                    ---------------------    --------------------

DEFERRED INCOME TAX LIABILITY                                                                   433,400                 423,000
DEFERRED INCOME                                                                                  15,966                  17,166
LONG-TERM DEBT- LESS CURRENT MATURITIES                                                         885,299                 282,686
                                                                                    ---------------------    --------------------
     TOTAL LIABILITIES                                                                        2,381,649               1,369,346
                                                                                    ---------------------    --------------------

COMMITMENTS AND CONTINGENT LIABILITIES
SHAREHOLDERS' EQUITY
     Preferred stock, $.01 par value - authorized, 1,000,000 shares; none issued
     and  outstanding. Common  stock,  $.01 par value,  authorized  - 10,000,000
     shares; issued  6,458,021 shares in 2000 and 6,446,832 shares in 1999                       64,581       $          64,468
     Additional paid-in capital                                                               6,226,894               6,200,701
     Retained earnings                                                                        4,018,904               3,856,038
                                                                                    ---------------------    --------------------
                                                                                             10,310,379              10,121,207
     Less 43,910 shares of treasury stock, at cost                                             (106,032)               (106,032)
                                                                                    ---------------------    --------------------
     Total Shareholders' Equity                                                              10,204,347              10,015,175
                                                                                    ---------------------    --------------------
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY                                          $        12,585,996       $      11,384,521
                                                                                    =====================    ====================
</TABLE>

See  accompanying  notes to  condensed  financial  statements.
*  Derived  from audited financial statements.

                                      -2-
<PAGE>


                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY
                   CONDENSED CONSOLIDATED STATEMENTS OF INCOME
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                                          Three Months Ended March 31,
                                                                                        2000                     1999
                                                                                ---------------------     -------------------
Revenues:
<S>                                                                             <C>                       <C>
     Services                                                                   $         2,389,174        $       2,114,674
     Product sales                                                                           81,430                   81,384
                                                                                ---------------------     -------------------
                                                                                          2,470,604                2,196,058
Costs and Expenses (Income):
     Costs related to services                                                              995,394                  804,269
     Costs of products sold                                                                  53,378                   78,444
     Selling, general and administrative expenses                                         1,135,571                  887,263
     Interest expense                                                                        14,307                    5,515
     Other income                                                                            (8,912)                  (7,527)
                                                                                ---------------------     -------------------

Income before provisions for income taxes                                                   280,866                  428,092

     Provision for income taxes                                                             118,000                  188,000
                                                                                ---------------------     -------------------

NET INCOME                                                                      $           162,866       $          240,092
                                                                                =====================     ===================

Net income per share:
     Basic                                                                      $               .03       $              .04
                                                                                ---------------------     -------------------
     Diluted                                                                    $               .03       $              .04
                                                                                ---------------------     -------------------

Weighted average number of common shares outstanding (Note 3)
     Basic                                                                                6,407,057                6,365,279
                                                                                =====================     ===================

     Diluted                                                                              6,416,524                6,601,083
                                                                                =====================     ===================
</TABLE>

See accompanying notes to condensed financial statements.

                                      -3-
<PAGE>


                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY

                 CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                                          Three Months Ended March 31,
                                                                                         2000                      1999
                                                                                 ---------------------     ---------------------
Cash flows From Operating Activities:

<S>                                                                              <C>                       <C>
     Net Income                                                                  $        162,866          $        240,092

     Adjustments  to  reconcile  net income to net cash  provided by  operating
         activities
     Depreciation and amortization                                                           414,712                  305,241
     Loss on unrecovered leased medical equipment                                             17,795                   32,800
     Change in Assets and Liabilities:
     Decrease (Increase) in receivables                                                     (417,583)                 102,440
     (Increase) Decrease in inventory                                                        (73,629)                (164,416)
     (Increase) in prepaid expenses and other assets                                        ( 31,663)                (167,686)
     Increase in  accounts  payable,  accrued  expenses  and taxes
         payable                                                                             325,382                  144,083
                                                                                 ---------------------     ---------------------

Net Cash Provided by Operating Activities                                                    397,880                  492,554
                                                                                 ---------------------     ---------------------

Cash Flows Used In Investing Activities:
     Net expenditures for fixed assets                                                    (1,110,938)                (712,295)
     Increase in notes receivable                                                           (295,621)                      --
     Payment for account acquisitions                                                       (292,000)                      --
                                                                                 ---------------------     ---------------------

Net Cash Used In Investing Activities                                                     (1,698,559)                (712,295)
                                                                                 ---------------------     ---------------------

Cash Flows From Financing activities:
     Increase in notes payable - bank                                                        600,000                       --
     Increase in loans payable                                                               (48,579)                  23,616
     Net proceeds upon exercise of stock options                                              26,306                   62,143
                                                                                 ---------------------     ---------------------

Net Cash Provided by Financing Activities                                                    577,727                   85,759
                                                                                 ---------------------     ---------------------
</TABLE>

See accompanying notes to condensed financial statements.

                                      -4-

<PAGE>


                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY

           CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                                       Three Months Ended March 31,
                                                                                       2000                     1999
                                                                              --------------------     --------------------

<S>                                                                           <C>                      <C>
         Net Decrease in Cash                                                 $        (722,952)       $        (142,982)

         Cash, Beginning of Period                                                        953,734               1,419,842
                                                                              --------------------     --------------------
         Cash, End of Period                                                  $                        $
                                                                                          230,782               1,276,860
                                                                              ====================     ====================

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:

CASH PAID DURING THE PERIOD FOR INTEREST                                      $           14,308       $            5,515
                                                                              ====================     ====================
CASH PAID DURING THE PERIOD FOR INCOME TAXES                                  $           59,105       $          105,855
                                                                              ====================     ====================
</TABLE>

See accompanying notes to condensed financial statements.


                                      -5-
<PAGE>


                   AMERICAN MEDICAL ALERT CORP. AND SUBSIDIARY


              Notes to Condensed Consolidated Financial Statements
                                   (Unaudited)

1.   General:

         These  financial  statements  should  be read in  conjunction  with the
financial  statements  and notes  thereto for the year ended  December  31, 1999
included in the Company's Annual Report on Form 10-KSB.

2.   Results of Operations:

         In the opinion of  management,  the  accompanying  unaudited  condensed
financial  statements  contain  all  adjustments   (consisting  only  of  normal
recurring  accruals)  necessary to present  fairly the financial  position as of
March 31,  2000,  and the  results  of  operations  and cash flows for the three
months ended March 31, 2000 and 1999.

         The accounting  policies used in preparing these  financial  statements
are the same as those described in the December 31, 1999 financial statements.

         The results of operations for the three months ended March 31, 2000 are
not  necessarily  indicative of the results to be expected for any other interim
period or for the full year.

3.   Earnings Per Share

         In February 1997, the Financial  Accounting Standards Board issued SFAS
No. 128,  "Earnings  per Share" which  changes the  methodology  of  calculating
earnings per share. SFAS No. 128 requires the disclosure of diluted earnings per
share  regardless of its difference  from basic earnings per share.  The Company
adopted  SFAS No. 128 in December  1997.  Earnings  per share data for the three
months  ended  March 31,  2000 and 1999 is  presented  in  conformity  with this
pronouncement.

         The  following  table  is  a  reconciliation   of  the  numerators  and
denominators in computing earnings per share:
<TABLE>
<CAPTION>

                                                             Income                  Shares                Per-Share
                    March 31, 2000                         (Numerator)            (Denominator)             Amounts
                    --------------                       -------------            -------------        ------------
<S>                                                      <C>                     <C>                 <C>
         Basic EPS -
             Income available to
                  common Stockholders                    $     162,866               6,407,057            $.03
                                                                                                          ====
         Effect of dilutive securities -
             Options and warrants                                   -                    9,467
                                                         -------------          --------------
</TABLE>

                                      -6-

<PAGE>
<TABLE>
<CAPTION>

<S>                                                      <C>                     <C>                 <C>
         Diluted EPS -
             Income available to common
                  Stockholders and
                  assumed conversions                    $     162,866               6,416,524            $.03
                                                         =============          ==============            ====

                     March 31,1999
                     -------------

         Basic EPS -
             Income available to
                  common stockholders                    $     240,092               6,365,279            $.04
                                                                                                          ====
         Effect of dilutive securities -
             Options and warrants                                   -                  235,804
                                                         -------------          --------------

         Diluted EPS -
             Income available to common
                  Stockholders and

                  assumed conversions                    $     240,092               6,601,083            $.04
                                                         =============          ==============            ====
</TABLE>



4.       Major Customers:

The  Company  is an  approved  Medicaid  Provider  in the states of New York and
Georgia and Illinois,  amongst  others.  During the three months ended March 31,
2000 and 1999 the Company had revenue from one contract with a  municipality  in
New York State which represented, respectively, 36% and 46% of total revenue for
each period.  The contract was effective through June 30, 1999. In January 1999,
the Company  submitted its proposal to the  municipality to renew and extend the
contract.  Since June 30, 1999, the Company has continued to provide  service to
the municipality while awaiting its selection of a provider. Even if the Company
does receive the renewal of the  contract,  there can be no  assurance  that the
same level of revenues will be sustained  due to a variety of factors  including
pricing, number of subscribers to be serviced, the competitive nature of the bid
process,  and the amount of time that passes before  renewal  agreement is acted
upon by the  municipality.  Depending  on how HCSP may award the  renewal of the
agreement,  pricing on an individual  subscriber basis may be lower than current
levels. If the municipality does not renew the contract, a significant amount of
the Company's  revenue would be lost, which would have a material adverse effect
on operating results, and in addition,  there most likely would be a significant
write-down of the Company's  leased medical devices (and/or a reduction in their
remaining  useful lives) and medical  devices held for lease.  The extent of the
write down will be dependent upon the length of the transition period to the new
provider.  As of March 31, 2000 and December 31, 1999 accounts  receivable  from
the contract  represented 62% of accounts  receivable and leased medical devices
in service under the contract  represented  38% of leased  medical  devices.  In
addition,  a substantial  amount of the Company's medical devices held for lease
at March 31, 2000 are intended  primarily for this  contract.  At March 31, 2000
the Company has incurred legal and other fees of approximately $147,000 relating
to the contract extension. Such costs have been classified as deferred costs and
will be amortized  over the new contract  term or written off if the contract is
not renewed.


                                      -7-
<PAGE>


ITEM 2. MANAGEMENT'S  DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        ------------------------------------------------------------------------
OF OPERATIONS.
--------------

The following  discussion and analysis  provides  information  which  management
believes is relevant to an assessment and understanding of the Company's results
of  operations  and  financial  condition.  The  discussion  should  be  read in
conjunction with the consolidated  financial  statements contained in the latest
Annual Report dated December 31, 1999.

This  discussion  contains  forward-looking  statements  which,  in  addition to
assuming a  continuation  of the degree and timing of customer  utilization  and
rate of renewals of contracts with the Company at historical levels, are subject
to a number of known and unknown  risks that,  in addition to general  economic,
competitive  and  other  business   conditions,   could  cause  actual  results,
performance  and  achievements  to differ  materially  from those  described  or
implied in the forward-looking statements.

LIQUIDITY AND CAPITAL RESOURCES
-------------------------------

The Company has a $2,000,000  Revolving  Credit Facility (the "Facility") with a
bank expiring May 31, 2001 (based upon 75% of eligible  accounts  receivable and
25% of  inventory,  as defined in the agreement  with respect to the  Facility).
Borrowings  under the Facility  bear  interest at the lower of the prime rate or
the LIBOR Rate plus 2.50% and is collateralized  by the Company's assets.  There
is $600,000 and $800,000 outstanding under the Facility as of March 31, 2000 and
May 8, 2000,  respectively.  The agreement with respect to the Facility provides
for negative and affirmative  covenants  including those related to tangible net
worth,  working capital and other borrowing.  At December 31, 1999 there were no
amounts outstanding under the Facility.

The Company's  working  capital on March 31, 2000 was  $3,241,205 as compared to
$3,853,000 on December 31, 1999.  During 2000, the Company  anticipates  that it
will make capital investments of approximately $3,000,000 of which approximately
$1,000,000 was expended during the first quarter.  Of the amount expended in the
first quarter,  approximately  $760,000 was used for the design,  production and
purchase of additional systems which the Company intends to rent. The balance of
$240,000 has been used primarily for the enhancement of management  information
systems.

During the three months ended March 31, 2000, the Company made a secured loan of
$300,000 to a provider agency to assist that agency in the expansion of its PERS
business.  In  addition,  as part of the  Company's  acquisition  strategy,  the
Company paid  $292,000  during the three months ended March 31, 2000 to purchase
and/ or convert to its systems,  various local and national  provider  agencies.
The Company believes that its present cash and working capital position, its

                                      -8-
<PAGE>

borrowing  availability and future anticipated income will be sufficient to meet
its cash and working capital needs for the foreseeable future.

The Company derives a significant  portion of its revenue from one contract with
the City of New York's Medicaid  Homecare  Services  Program (HCSP).  During the
three  months  ended March 31, 2000 and 1999,  the Company had revenue from this
contract , which  represented 36% and 46%,  respectively,  of total revenues for
each period.  As of March 31, 2000 and December  31, 1999,  accounts  receivable
from the contract represented 62% of accounts receivable. Leased medical devices
in service  relating to this contract  represented  38% of total leased  medical
devices at March  31,2000 and  December  31,  1999,  Inventory  relating to this
contract  represented  approximately 20% of total inventory on hand at March 31,
2000 and December 31, 1999.  The contract with HCSP expired on June 30, 1999 and
the Company  continues  to service New York City's  Medicaid  Homecare  Services
Program (HCSP) under the terms and conditions of the contract that expired.

In January 1999, the Company and several other companies  submitted proposals to
provide  PERS  services on behalf of the City of New York through June 30, 2003.
On October 22, 1999,  the Company was advised by HCSP that  another  company had
been  preliminarily  recommended.   The  Company's  management  reviewed  HCSP's
preliminary  recommendation  and  assessed  alternative  options  and courses of
action.  On November 1, 1999, the Company submitted a formal protest pursuant to
paragraph 4-04 of the Rules of the  Procurement  Policy Board of the City of New
York to contest the  preliminary  award. As of May 8, 2000, the contract had not
been awarded;  however,  the Company continues as the current vendor and current
revenues  and the  current  subscriber  base  relating  to this  agreement  have
increased slightly since the levels achieved in the 1st quarter of 1999.

If  the  City  of  New  York  HCSP  awards  the  contract  to  another   vendor,
approximately  36% of the Company's  revenues  would be lost,  having a material
adverse effect on operating  results and cash flow. In addition,  it is possible
that significant  adjustments to inventory and fixed assets  associated with the
contract would occur.  Based upon a transition method selected by HCSP, it could
be expected that revenues from HCSP would continue on a diminishing  scale until
all units are removed.  However,  at this time, no determination  can be made on
how the  transition  to another  vendor would be  accomplished  and in what time
frame the transition would be made, and thus the full financial impact cannot be
assessed  at this time.  Even if the  Company  does  receive  the renewal of the
contract,  there can be no  assurance  that the same level of  revenues  will be
sustained due to a variety of factors including  pricing,  number of subscribers
to be serviced,  the  competitive  nature of the bid process,  and the amount of
time that passes before the renewal  agreement is acted upon by HCSP.  Depending
on how HCSP may award the  renewal of the agreement,  pricing  on an  individual
subscriber basis may be lower than current levels.

In light of the  possibility  that the  Company's  contract with HCSP may not be
renewed,  the Company's management has developed a business plan to minimize the
potential loss through reductions in HCSP related overhead and the re-deployment
of assets to other programs. In addition, the Company will continue to build its
subscriber  base through  consumers,  healthcare  agencies,  health  maintenance
organizations,  durable medical  equipment  providers,  retirement  communities,
hospitals  and  other  governmental   agencies.  In  addition,  the  Company  is
continuing to invest in new products and services.

                                      -9-
<PAGE>

RESULTS OF OPERATIONS
---------------------

Revenue from services  (recurring monthly revenues,  RMR) increased $274,500 for
the three months ended March 31, 2000 as compared to the same period in 1999, an
increase of 13%. The Company  continues  to see strong  results in the growth of
RMR resulting from refocusing its sales and marketing efforts towards the growth
of the subscriber  base,  rental income and service  revenues.  Costs related to
services as a  percentage  of RMR for the three  months ended March 31, 2000 and
1999 were 42% and 38%, respectively.  This increase in costs related to services
resulted from increased  depreciation of medical  devices,  additional  response
center personnel, and increases in telecommunication costs.

Revenue from product sales for the three months ended March 31, 2000 as compared
to the same period in 1999 remained  virtually the same. Gross profit on product
sales  for the  three  months  ended  March  31,  2000 and 1999 was 34% and 4%,
respectively.  Gross  profit  increased  in 2000 as a result  of the sale of the
Company's new Model 450 Smart  Activator and sales of the Company's  products to
retirement facilities, which are at higher profit margins.

Selling, general and administrative expenses increased by $248,308 for the three
months ended March 31, 2000 as compared to the same period in 1999,  an increase
of 28%. Selling,  general and administrative expense as compared as a percentage
of total  revenues  for the three  months ended March 31, 2000 and 1999 were 46%
and 40%  respectively.  Additional  expenses incurred in 2000 were the result of
the  hiring  of  executive  and  management  personnel,  expansion  of the sales
department, and increased sales and marketing expenses.

Interest expense for the three months ended March 31, 1999 and 1998 was $14,307
and $5,515,  respectively.  Interest in 2000 increased as a result of additional
capital equipment leases and increases in average monthly borrowings.

The  Company's  income  before  provision  for income taxes for the three months
ended March 31, 2000 was  $280,866,  a decrease of $ 147,226 from 1999,  or 34%.
The decrease in 2000 resulted  from an increase in the  Company's  operating and
selling and administrative costs, offset by an increase in service revenues.

                                      -10-

<PAGE>


                           PART II - OTHER INFORMATION

ITEM 6. EXHIBIT AND REPORTS ON FORM 8-K.

(a)  Exhibits:


         27.  Financial Data Schedule

(b)  Reports on Form 8-K:


         No reports on Form 8-K were filed.


                                      -11-

<PAGE>


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company
has duly  caused  this  report  to be signed  on its  behalf by the  undersigned
thereunto duly authorized.

                                         AMERICAN MEDICAL ALERT CORP.

Dated:  May 15, 2000                          By: /s/ Howard M. Siegel
                                                  -----------------------------
                                                  Howard M. Siegel
                                                   President
                                                     & Chief Operating Officer

                                              By: /s/ Corey M. Aronin
                                                  -----------------------------
                                                  Corey M. Aronin
                                                     Chief Financial Officer
                                      -12-